Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Barrin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 27, 2023
Live Imaging of CAR T Cell Ca<sup>2+</sup> Signals in Tumor Slices Using Confocal MicroscopyDavid Espie, Sarah Barrin, Irena Rajnpreht, et al.
Journal of Visualized Experiments : Jove|January 25, 2018
Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal MicroscopyElisa Peranzoni, Houcine Bougherara, Sarah Barrin, et al.
Cancers|October 14, 2022
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid CancersYasmine Lounici, Olivia Le Saux, Gabriel Chemin, et al.
Critical Reviews in Oncology/Hematology|December 5, 2020
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the artOlivia Le Saux, Yasmine Lounici, Pauline Wajda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2020
Extracellular Release of Antigen by Dendritic Cell Regurgitation Promotes B Cell Activation through NF-κB/cRelHoussam El-Barbry, Marisa Capitao, Sarah Barrin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2018
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatmentElisa Peranzoni, Jean Lemoine, Lene Vimeux, et al.
Elife|June 9, 2021
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatmentAlba Nicolas-Boluda, Javier Vaquero, Lene Vimeux, et al.
Cancer Immunology Research|October 23, 2021
CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1Chahrazade Kantari-Mimoun, Sarah Barrin, Lene Vimeux, et al.
Therapeutic Advances in Medical Oncology|August 11, 2025
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacyOlivia Le Saux, Renaud Sabatier, Isabelle Treilleux, et al.
Nature Communications|July 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinomaOlivia Le Saux, Maude Ardin, Justine Berthet, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|April 27, 2023
Live Imaging of CAR T Cell Ca<sup>2+</sup> Signals in Tumor Slices Using Confocal MicroscopyDavid Espie, Sarah Barrin, Irena Rajnpreht, et al.
Journal of Visualized Experiments : Jove|January 25, 2018
Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal MicroscopyElisa Peranzoni, Houcine Bougherara, Sarah Barrin, et al.
Cancers|October 14, 2022
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid CancersYasmine Lounici, Olivia Le Saux, Gabriel Chemin, et al.
Critical Reviews in Oncology/Hematology|December 5, 2020
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the artOlivia Le Saux, Yasmine Lounici, Pauline Wajda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2020
Extracellular Release of Antigen by Dendritic Cell Regurgitation Promotes B Cell Activation through NF-κB/cRelHoussam El-Barbry, Marisa Capitao, Sarah Barrin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2018
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatmentElisa Peranzoni, Jean Lemoine, Lene Vimeux, et al.
Elife|June 9, 2021
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatmentAlba Nicolas-Boluda, Javier Vaquero, Lene Vimeux, et al.
Cancer Immunology Research|October 23, 2021
CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1Chahrazade Kantari-Mimoun, Sarah Barrin, Lene Vimeux, et al.
Therapeutic Advances in Medical Oncology|August 11, 2025
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacyOlivia Le Saux, Renaud Sabatier, Isabelle Treilleux, et al.
Nature Communications|July 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinomaOlivia Le Saux, Maude Ardin, Justine Berthet, et al.
Pageof 1